Koch Institute for Integrative Cancer Research

Koch Institute for Integrative Cancer Research

The Koch Institute aims to revolutionize the diagnosis, monitoring, and treatment of cancer by integrating the most advanced biological investigation with the best in engineering technology.  The Koch Institute includes over 40 laboratories and more than 650 researchers located at our headquarters and across the MIT campus. This group includes cancer biologists, genome scientists, chemists, engineers, and computer scientists, all dedicated to bringing the most advanced science and technology to bear in the fight against cancer.  The cross-disciplinary teams of faculty, students, and staff at the Institute work in five areas of research that are critical for rapid progress toward controlling cancer:

  • Developing nanotechnology-based cancer therapeutics
  • Creating novel devices for cancer detection and monitoring
  • Exploring the molecular and cellular basis of metastasis
  • Advancing personalized medicine through analysis of cancer pathways and drug resistance
  • Engineering the immune system to fight cancer

IN THE NEWS